Mitoxantrone Hydrochloride

CAS 70476-82-3 3 current records 4 historicalSmall Molecule

Who holds supplier records for Mitoxantrone Hydrochloride? 3 organisations hold a current record for Mitoxantrone Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (2) and Australia (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Mitoxantrone Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/mitoxantrone-hydrochloride

Reading the evidence

  • 3 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in China

    2 of the 3 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (3)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Mitoxantrone Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Mitoxantrone Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Mitoxantrone Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 4 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
WUHAN CALMLAND PHARMACEUTICALS CO., LTD. WuhanCN
CEP 2023-342 - Rev 00
Mitoxantrone hydrochloride
Jul 2025Inspected Apr 2026
Croatia
Chongqing Carelife Pharmaceutical Co. Ltd. ChongqingCN
R1-CEP 2001-143 - Rev 05
Mitoxantrone hydrochloride
Jun 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Mitoxantrone Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • India · Inactive DMF 19309, 10858 · filed Mar 2007
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 15879 · filed Feb 2002
  • Czechia · Inactive DMF 12046 · filed Jul 1996
  • HEINRICH MACK NACHF
    Inactive DMF 5203 · filed Jan 1984

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Mitoxantrone Hydrochloride is a synthetic antineoplastic agent used in the treatment of certain types of cancer and multiple sclerosis. It works by intercalating into DNA, disrupting replication and transcription processes.

Chemical identity

IUPAC name
1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;dihydrochloride
Canonical SMILES
C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO.Cl.Cl
InChIKey
ZAHQPTJLOCWVPG-UHFFFAOYSA-N
Synonyms
Novantrone API, cl 232,315, cl-232315, mitoxantrone dihydrochloride, mitoxantrone hcl, novantrone, nsc-301739

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Topoisomerase Inhibitor
Mechanism of action
Topoisomerase Inhibitors

Therapeutic areas

OncologyMultiple Sclerosis

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Mitoxantrone Hydrochloride?

3 organisations hold an active US FDA Type II Drug Master File or a CEP for Mitoxantrone Hydrochloride: CHONGQING CARELIFE PHARMACEUTICAL CO LTD (China), IDT AUSTRALIA LTD (Australia) and WUHAN CALMLAND PHARMACEUTICALS CO LTD (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Mitoxantrone Hydrochloride Drug Master Files are active?

CHONGQING CARELIFE PHARMACEUTICAL CO LTD (DMF 12262, 43253) and IDT AUSTRALIA LTD (DMF 12328). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Mitoxantrone Hydrochloride records mean?

4 organisations have only inactive Type II DMFs for Mitoxantrone Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Mitoxantrone Hydrochloride have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Mitoxantrone Hydrochloride on the EDQM register, including WUHAN CALMLAND PHARMACEUTICALS CO., LTD. Wuhan (CN) and Chongqing Carelife Pharmaceutical Co. Ltd. Chongqing (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Mitoxantrone Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Mitoxantrone Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.